The U.K.'s Royal Marsden NHS Foundation Trust has treated its first patient using a new online adaptive replanning module released in the latest version of the RayStation radiation treatment planning system.
For centers using the software RayStation and RayCare, the module may be implemented regardless of the type of treatment machine, paving the way for a wider implementation of online adaptive radiotherapy, according to RaySearch Laboratories.
The treatment was carried out in March using Accuray’s linear accelerator Radixact, RayStation, and The Royal Marsden’s existing oncology information system, RaySearch said.
"With this treatment, The Royal Marsden has demonstrated the effectiveness and efficiency of the new module in RayStation, and while this is a significant step forward in terms of time savings, both for patients and for the hospital, there remains potential for further optimization in how the involved systems communicate," RaySearch added.
The Royal Marsden Cancer Charity funded the equipment, and teams will collaborate to continue refining the integration, RaySearch said.
"Being able to tailor each treatment session to the patient’s current anatomy, while the patient is on the treatment bed, is a major step forward in delivering more personalized cancer care," stated Dr. Susan Lalondrelle, consultant clinical oncologist at The Royal Marsden NHS Foundation Trust, in RaySearch's announcement.
The patient was treated radically for endometrial cancer.
RaySearch noted the products are subject to regulatory clearance in some markets.
